U.S., Oct. 22 -- An application to own the trademark for 'OPTILEUKIN' has been filed on Apr. 25, 2025.
Owner(s):
InVitria, Inc.; 2718 Industrial Drive, , KANSAS
Goods and/or Services:
For: Chemicals, namely, non-animal derived cell culture media for promoting cell growth, optimization, and productivity, for medical or veterinary purposes; Recombinant cytokine proteins for use as cell growth media for growing cells for clinical use; Recombinant cytokine proteins for use as reagents for clinical medical purposes; Recombinant cytokine protein arrays for clinical medical diagnosis purposes; Recombinant cytokine proteins sold as a component ingredient of therapeutic pharmaceuticals for the treatment of immune system related diseases and diso...